Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells

Devil facial tumour disease (DFTD) is a transmissible cancer that has brought the host species, the Tasmanian devil, to the brink of extinction. The cancer cells avoid allogeneic immune recognition by downregulating cell surface major histocompatibility complex (MHC) I expression. This should prevent CD8(+) T cell, but not natural killer (NK) cell, cytotoxicity. The reason why NK cells, normally reactive to MHC-negative cells, are not activated to kill DFTD cells has not been determined. The immune response of wild devils to DFTD, if it occurs, is uncharacterised. To investigate this, we tested 12 wild devils with DFTD, and found suggestive evidence of low levels of antibodies against DFTD cells in one devil. Eight of these devils were also analysed for cytotoxicity, however, none showed evidence for cytotoxicity against cultured DFTD cells. To establish whether mimicking activation of antitumour responses could induce cytotoxic activity against DFTD, Tasmanian devil peripheral blood mononuclear cells (PBMCs) were treated with either the mitogen Concanavalin A, the Toll-like receptor agonist polyinosinic:polycytidylic acid or recombinant Tasmanian devil IL-2. All induced the PBMC cells to kill cultured DFTD cells, suggesting that activation does not occur after encounter with DFTD cells in vivo, but can be induced. The identification of agents that activate cytotoxicity against DFTD target cells is critical for developing strategies to protect against DFTD. Such agents could function as adjuvants to induce functional immune responses capable of targeting DFTD cells and tumours in vivo.

Marsupial immunology bounding ahead

Marsupial immune responses were previously touted as ‘primitive’ but we now know that the marsupial immune system is complex and on par with that of eutherian mammals. In this manuscript we review the field of marsupial immunology, focusing on basic anatomy, developmental immunology, immunogenetics and evolution. We concentrate on advances to our understanding of marsupial immune gene architecture, made possible by the recent sequencing of the opossum, tammar wallaby and Tasmanian devil genomes. Characterisation of immune gene sequences now paves the way for the development of immunological assays that will allow us to more accurately study health and disease in marsupials.

Marsupial genome sequences: providing insight into evolution and disease

Marsupials (metatherians), with their position in vertebrate phylogeny and their unique biological features, have been studied for many years by a dedicated group of researchers, but it has only been since the sequencing of the first marsupial genome that their value has been more widely recognised. We now have genome sequences for three distantly related marsupial species (the grey short-tailed opossum, the tammar wallaby, and Tasmanian devil), with the promise of many more genomes to be sequenced in the near future, making this a particularly exciting time in marsupial genomics. The emergence of a transmissible cancer, which is obliterating the Tasmanian devil population, has increased the importance of obtaining and analysing marsupial genome sequence for understanding such diseases as well as for conservation efforts. In addition, these genome sequences have facilitated studies aimed at answering questions regarding gene and genome evolution and provided insight into the evolution of epigenetic mechanisms. Here I highlight the major advances in our understanding of evolution and disease, facilitated by marsupial genome projects, and speculate on the future contributions to be made by such sequences.

The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells

The Tasmanian devil (Sarcophilus harrisii) is under threat of extinction due to a fatal infectious neoplastic disease, named Devil Facial Tumour Disease. Tumours are transferred as allografts between animals and no effective immune response or host resistance to the disease has been detected, raising interest in the immune function of the species. To investigate whether Tasmanian devils had a competent humoral immune response, four devils were immunised with horse red blood cells (HRBC) either intraperitoneally or subcutaneously. Antibody responses were measured by direct and indirect haemagglutination assays for a period of up to 40 weeks. Primary responses were well defined, but secondary responses were prominent only in the devils immunised subcutaneously. All devils showed evidence for a memory antibody response following a booster given 32 weeks after the first injection and this was more evident with the subcutaneous route. Tasmanian devils tested were capable of mounting a humoral immune response against HRBC and the subcutaneous injection in the presence of the adjuvant Montanide was a safe and effective route.

Aerial baiting with 1080 to control wild dogs does not affect the populations of two common small mammal species

More than most other animal control techniques, toxic baiting is fraught with the potential impact on non-target species. In the present study, we investigated the effect of aerial baiting with 1080 to control wild dogs in north-eastern New South Wales (NSW), Australia, on populations of southern bush rats (Rattus fuscipes assimilis) and brown antechinus (Antechinus stuartii), using a controlled experiment. Six populations, three each within widely spaced baited and unbaited trapping grids, were monitored before and after bait laying. To develop capture–mark–recapture indices, separate 4-day trapping surveys were undertaken twice before and twice after meat baits (250 g containing 6 mg sodium fluoroacetate, 1080) were delivered from a helicopter at 40 baits per kilometre. To assess non-fatal bait consumption, all baits contained rhodamine B (RhB), which gets incorporated into the vibrissae of animals that have ingested this marker. Neither mammal population decreased in size after baiting, nor was there any increase in population turnover rates or changes in the movement patterns of either species. Furthermore, no trapped animal tested positive for RhB, suggesting that these small mammals rarely consume meat baits, and that, at the population level, the impact of baiting on them was likely negligible. It is therefore unlikely that the current practise of aerial baiting in NSW, although effective in reducing dog activity, threatens populations of these two common species and perhaps small mammals in general.

Assessment of cellular immune responses of healthy and diseased Tasmanian devils (Sarcophilus harrisii)

The Tasmanian devil (TD) (Sarcophilus harrisii) is under threat from devil facial tumour disease (DFTD), a cancer that is transmitted between devils by direct cell implantation. As no devil is known to have rejected the tumour allograft, an understanding of the immune status of this species is essential to help explain the unique infectious nature of this cancer. We analysed differential white blood cell counts, the phagocytic response of neutrophils as well as mitogen-induced lymphocyte proliferation. Devils analysed included healthy TDs kept in captivity, healthy devils from disease-free and diseased areas as well as diseased devils. Neutrophils isolated from the peripheral blood of healthy devils showed competent phagocytosis and peripheral blood mononuclear cells from healthy and diseased devils proliferated in response to Con A, PHA and PWM stimulation. Although a wide range of responses was observed and relatively high doses of mitogens were required, there was no significant difference between males and females, adults and juveniles or between normal and diseased animals, suggesting that transmission of DFTD is not a consequence of a severely impaired immune system. As lymphocytes from all TDs appear to require strong stimulation for activation, this threshold may contribute to all devils being susceptible to DFTD.

Establishing long-term colonies of marsupials to provide models for studying developmental mechanisms and their application to fertility control

To study marsupial developmental mechanisms and their application to fertility control, it is necessary to develop reliable procedures for breeding, colony maintenance, reproductive monitoring for obtaining known-age embryos and, if possible, an induced ovulation protocol. These procedures also provide means to enhance conservation of endangered species. Such procedures are examined in the stripe-faced dunnart, an excellent model for developmental analysis, and the common brush-tail possum, an agricultural and ecological pest species in New Zealand that has become a model for fertility control in marsupials. A long-term colony of the stripe-faced dunnart has been in existence for 21 years, and the procedures for its maintenance and continued survival are outlined, and include minimal reproductive contributions from wild-caught animals, and development of an appropriate timetable of development and induced-ovulation protocols. Common brushtail possum colonies are relatively frequent but have regular input from wild-caught animals. Procedures that minimise competition for prized resources and allow successful group housing of possums are outlined. For both species the available development timetables, in vitro techniques and induced ovulation protocols are essential tools for the study of developmental mechanisms and fertility control, respectively, and also have considerable implications for conservation of these and other species.

Application of pharmaceutical drug delivery for biological control of the common brushtail possum in New Zealand: a review

The common brushtail possum (Trichosurus vulpecula) is the most significant vertebrate pest in New Zealand, being a major ecological threat to the indigenous biodiversity and an economic threat as a vector for bovine tuberculosis. Novel and effective strategies to reduce the population of T. vulpecula are needed urgently. Several biocontrol agents are currently being assessed and from research to date it is likely that the biocontrol agents will be peptide or protein molecules. It is not possible to administer such biocontrol agents alone because they would be degraded rapidly in the animal, especially if delivered orally. Technologies used in the pharmaceutical industry to design efficacious drug-delivery systems for humans and animals can be applied to the design of delivery systems for biocontrol agents used in wildlife management, although there are some unique challenges that must be overcome.